| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Ing Investment Management Europe B V | Institution | 25,107 | New Holding | 25,107 | 100 % | $702,745 | $702,745 | $0 | 0.00 % | $0 | | | | | | News Article | History of Ing Investment Management Europe B V Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Janus Capital Management Llc | Institution | 669,063 | Sold Some | -38,080 | -5.38 % | $18,727,073 | $18,727,073 | $0 | 0.00 % | $0 | | | | | | News Article | History of Janus Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | N-Q | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | | Sold All | -33,740 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-19 | 2009-09-30 | 13F-HR/A | Rbc Asset Management Inc | Institution | | Sold All | -16,200 | -100 % | | | | 0.35 % | $-1,620 | | | | | | News Article | History of Rbc Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Jane Street Holding Llc | Institution | | Sold All | -32,099 | -100 % | | | | -2.23 % | $20,543 | | | | | | News Article | History of Jane Street Holding Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Institutional Funds Inc - Small Cap Growth Fund | Small-Cap Growth | 850 | No Compare | | | $24,336 | $23,792 | $-544 | -2.23 % | | | | | | | News Article | History of Mutual Of America Institutional Funds Inc - Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Investment Corp - Small Cap Growth Fund | Small-Cap Growth | 44,134 | No Compare | | | $1,263,556 | $1,235,311 | $-28,246 | -2.23 % | | | | | | | News Article | History of Mutual Of America Investment Corp - Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Royal Bank Of Canada Trust Co Ltd | Institution | 21 | New Holding | 21 | 100 % | $601 | $588 | $-13 | -2.23 % | $-13 | | | | | | News Article | History of Royal Bank Of Canada Trust Co Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 4,816 | Added More | 1,431 | 42.27 % | $140,049 | $134,800 | $-5,249 | -3.74 % | $-1,560 | | | | | | News Article | History of Amvescap Plc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 18,000 | Sold Some | -48,477 | -72.92 % | $523,440 | $503,820 | $-19,620 | -3.74 % | $52,840 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 1,046,817 | Added More | 819,553 | 360.61 % | $30,441,438 | $29,300,408 | $-1,141,031 | -3.74 % | $-893,313 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Altrinsic Global Advisors Llc | Institution | 118,700 | Added More | 18,700 | 18.70 % | $3,419,747 | $3,322,413 | $-97,334 | -2.84 % | $-15,334 | | | | | | News Article | History of Altrinsic Global Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 49,970 | Added More | 3,912 | 8.49 % | $1,439,636 | $1,398,660 | $-40,975 | -2.84 % | $-3,208 | | | | | | News Article | History of American International Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aqr Capital Management Llc | Institution | 74,313 | New Holding | 74,313 | 100 % | $2,140,958 | $2,080,021 | $-60,937 | -2.84 % | $-60,937 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ashford Capital Management Inc | Institution | 466,100 | Sold Some | -27,000 | -5.47 % | $13,428,341 | $13,046,139 | $-382,202 | -2.84 % | $22,140 | | | | | | News Article | History of Ashford Capital Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Management Llc | No Data | 9,260 | Sold Some | -81,429 | -89.78 % | $266,781 | $259,187 | $-7,593 | -2.84 % | $66,772 | | | | | | News Article | History of Bam Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bridger Management Llc | Institution | 480,801 | Sold Some | -242,405 | -33.51 % | $13,851,877 | $13,457,620 | $-394,257 | -2.84 % | $198,772 | | | | | | News Article | History of Bridger Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bridgeway Capital Management Inc | Institution | 24,400 | No Change | 0 | 0 % | $702,964 | $682,956 | $-20,008 | -2.84 % | $0 | | | | | | News Article | History of Bridgeway Capital Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital World Investors | Institution | 1,000,000 | No Change | 0 | 0 % | $28,810,000 | $27,990,000 | $-820,000 | -2.84 % | $0 | | | | | | News Article | History of Capital World Investors Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capstone Investment Advisors Llc | Institution | 15,493 | New Holding | 15,493 | 100 % | $446,353 | $433,649 | $-12,704 | -2.84 % | $-12,704 | | | | | | News Article | History of Capstone Investment Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Catapult Capital Management Llc | Institution | 45,000 | New Holding | 45,000 | 100 % | $1,296,450 | $1,259,550 | $-36,900 | -2.84 % | $-36,900 | | | | | | News Article | History of Catapult Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 68,405 | Added More | 27,155 | 65.83 % | $1,970,748 | $1,914,656 | $-56,092 | -2.84 % | $-22,267 | | | | | | News Article | History of Citadel L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cr Intrinsic Investors Llc | Institution | 625,000 | New Holding | 625,000 | 100 % | $18,006,250 | $17,493,750 | $-512,500 | -2.84 % | $-512,500 | | | | | | News Article | History of Cr Intrinsic Investors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Dafna Capital Management Llc | Institution | 67,345 | Sold Some | -84,355 | -55.60 % | $1,940,209 | $1,884,987 | $-55,223 | -2.84 % | $69,171 | | | | | | News Article | History of Dafna Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Deerfield Management Co | Institution | 563,738 | Sold Some | -216,576 | -27.75 % | $16,241,292 | $15,779,027 | $-462,265 | -2.84 % | $177,592 | | | | | | News Article | History of Deerfield Management Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | | Sold All | -13,400 | -100 % | | | | -2.84 % | $10,988 | | | | | | News Article | History of Eaton Vance Management Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Epoch Investment Partners Inc | Institution | 44,050 | Sold Some | -2,850 | -6.07 % | $1,269,081 | $1,232,960 | $-36,121 | -2.84 % | $2,337 | | | | | | News Article | History of Epoch Investment Partners Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | 500 | No Change | 0 | 0 % | $14,405 | $13,995 | $-410 | -2.84 % | $0 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 582,500 | Sold Some | -930,400 | -61.49 % | $16,781,825 | $16,304,175 | $-477,650 | -2.84 % | $762,928 | | | | | | News Article | History of Fmr Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Healthcor Management L P | Institution | 1,385,000 | New Holding | 1,385,000 | 100 % | $39,901,850 | $38,766,150 | $-1,135,700 | -2.84 % | $-1,135,700 | | | | | | News Article | History of Healthcor Management L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Highside Capital Management L P | Institution | 825,000 | Added More | 325,000 | 65.00 % | $23,768,250 | $23,091,750 | $-676,500 | -2.84 % | $-266,500 | | | | | | News Article | History of Highside Capital Management L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 478,943 | Added More | 130,506 | 37.45 % | $13,798,348 | $13,405,615 | $-392,733 | -2.84 % | $-107,015 | | | | | | News Article | History of Ing Groep Nv Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Loomis Sayles And Co L P | Institution | 78,586 | Sold Some | -3,460 | -4.21 % | $2,264,063 | $2,199,622 | $-64,441 | -2.84 % | $2,837 | | | | | | News Article | History of Loomis Sayles And Co L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Square Investors Llc | No Data | | Sold All | -434 | -100 % | | | | -2.84 % | $356 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Mazama Capital Management Inc | Institution | 113,330 | New Holding | 113,330 | 100 % | $3,265,037 | $3,172,107 | $-92,931 | -2.84 % | $-92,931 | | | | | | News Article | History of Mazama Capital Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 201,724 | New Holding | 201,724 | 100 % | $5,811,668 | $5,646,255 | $-165,414 | -2.84 % | $-165,414 | | | | | | News Article | History of Millennium Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 435,827 | Added More | 183,542 | 72.75 % | $12,556,176 | $12,198,798 | $-357,378 | -2.84 % | $-150,504 | | | | | | News Article | History of Morgan Stanley Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Noonday Asset Management L P | Institution | 55,000 | New Holding | 55,000 | 100 % | $1,584,550 | $1,539,450 | $-45,100 | -2.84 % | $-45,100 | | | | | | News Article | History of Noonday Asset Management L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Co Of Connecticut | Institution | | Sold All | -19,540 | -100 % | | | | -2.84 % | $16,023 | | | | | | News Article | History of Northern Trust Co Of Connecticut Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 742,550 | Added More | 116,298 | 18.57 % | $21,392,866 | $20,783,975 | $-608,891 | -2.84 % | $-95,364 | | | | | | News Article | History of Northern Trust Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 1,700 | Sold Some | -55,880 | -97.04 % | $48,977 | $47,583 | $-1,394 | -2.84 % | $45,822 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Orbimed Advisors Llc | Institution | | Sold All | -2,256,100 | -100 % | | | | -2.84 % | $1,850,002 | | | | | | News Article | History of Orbimed Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Palo Alto Investors Llc | Institution | 2,600,220 | Sold Some | -14,100 | -0.53 % | $74,912,338 | $72,780,158 | $-2,132,180 | -2.84 % | $11,562 | | | | | | News Article | History of Palo Alto Investors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Partner Fund Management Lp | Institution | | Sold All | -104,118 | -100 % | | | | -2.84 % | $85,377 | | | | | | News Article | History of Partner Fund Management Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Partner Investment Management Lp | Institution | | Sold All | -63,942 | -100 % | | | | -2.84 % | $52,432 | | | | | | News Article | History of Partner Investment Management Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Passport Management Llc | Institution | 362,800 | Added More | 97,300 | 36.64 % | $10,452,268 | $10,154,772 | $-297,496 | -2.84 % | $-79,786 | | | | | | News Article | History of Passport Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perceptive Advisors Llc | Institution | 70,000 | Sold Some | -130,000 | -65.00 % | $2,016,700 | $1,959,300 | $-57,400 | -2.84 % | $106,600 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Principled Asset Administration Llc | Institution | 475,000 | Sold Some | -188,800 | -28.44 % | $13,684,750 | $13,295,250 | $-389,500 | -2.84 % | $154,816 | | | | | | News Article | History of Principled Asset Administration Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Rafferty Asset Management Llc | Institution | 11,687 | New Holding | 11,687 | 100 % | $336,702 | $327,119 | $-9,583 | -2.84 % | $-9,583 | | | | | | News Article | History of Rafferty Asset Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 8,649 | New Holding | 8,649 | 100 % | $249,178 | $242,086 | $-7,092 | -2.84 % | $-7,092 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 4,388,472 | Added More | 827,416 | 23.23 % | $126,431,878 | $122,833,331 | $-3,598,547 | -2.84 % | $-678,481 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Sonar Capital Management Llc | Institution | | Sold All | -36,000 | -100 % | | | | -2.84 % | $29,520 | | | | | | News Article | History of Sonar Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Straus Capital Management Llc | Institution | 150,645 | Added More | 3,750 | 2.55 % | $4,340,082 | $4,216,554 | $-123,529 | -2.84 % | $-3,075 | | | | | | News Article | History of Straus Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Transamerica Investment Management Llc | Institution | 175,500 | New Holding | 175,500 | 100 % | $5,056,155 | $4,912,245 | $-143,910 | -2.84 % | $-143,910 | | | | | | News Article | History of Transamerica Investment Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Trellus Management Company Llc | Institution | | Sold All | -100,000 | -100 % | | | | -2.84 % | $82,000 | | | | | | News Article | History of Trellus Management Company Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 609,400 | Added More | 185,800 | 43.86 % | $17,556,814 | $17,057,106 | $-499,708 | -2.84 % | $-152,356 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 1,000 | Sold Some | -5 | -0.49 % | $28,810 | $27,990 | $-820 | -2.84 % | $4 | | | | | | News Article | History of Us Bancorp De Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Walleye Trading Llc | Institution | 25,854 | Added More | 25,274 | 4357.58 % | $744,854 | $723,653 | $-21,200 | -2.84 % | $-20,725 | | | | | | News Article | History of Walleye Trading Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weintraub Capital Management Lp | Institution | | Sold All | -100,000 | -100 % | | | | -2.84 % | $82,000 | | | | | | News Article | History of Weintraub Capital Management Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | 75,000 | Added More | 46,300 | 161.32 % | $2,160,750 | $2,099,250 | $-61,500 | -2.84 % | $-37,966 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 4,611,029 | Added More | 767,044 | 19.95 % | $132,843,745 | $129,062,702 | $-3,781,044 | -2.84 % | $-628,976 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 148,883 | Added More | 18,347 | 14.05 % | $4,211,900 | $4,167,235 | $-44,665 | -1.06 % | $-5,504 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 1,454,693 | Sold Some | -69,780 | -4.57 % | $41,153,265 | $40,716,857 | $-436,408 | -1.06 % | $20,934 | | | | | | News Article | History of Axa Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 85,442 | Added More | 47,072 | 122.67 % | $2,417,154 | $2,391,522 | $-25,633 | -1.06 % | $-14,122 | | | | | | News Article | History of Barclays Plc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Batterymarch Financial Management Inc | Institution | 90,220 | New Holding | 90,220 | 100 % | $2,552,324 | $2,525,258 | $-27,066 | -1.06 % | $-27,066 | | | | | | News Article | History of Batterymarch Financial Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 29,804 | Added More | 21,030 | 239.68 % | $843,155 | $834,214 | $-8,941 | -1.06 % | $-6,309 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital Fund Management S A | Institution | 3,924 | Added More | 3,440 | 710.74 % | $111,010 | $109,833 | $-1,177 | -1.06 % | $-1,032 | | | | | | News Article | History of Capital Fund Management S A Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caxton Associates Llc | Institution | 18,912 | New Holding | 18,912 | 100 % | $535,020 | $529,347 | $-5,674 | -1.06 % | $-5,674 | | | | | | News Article | History of Caxton Associates Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Clearbridge Advisors Llc | Institution | 491,759 | Sold Some | -4,347 | -0.87 % | $13,911,862 | $13,764,334 | $-147,528 | -1.06 % | $1,304 | | | | | | News Article | History of Clearbridge Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | | Sold All | -8,627 | -100 % | | | | -1.06 % | $2,588 | | | | | | News Article | History of Credit Agricole S A Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 90,500 | No Change | 0 | 0 % | $2,560,245 | $2,533,095 | $-27,150 | -1.06 % | $0 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Delaware Management Business Trust | Institution | 445,160 | Added More | 320,695 | 257.65 % | $12,593,576 | $12,460,028 | $-133,548 | -1.06 % | $-96,209 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Expo Capital Management Llc | Institution | | Sold All | -175,000 | -100 % | | | | -1.06 % | $52,500 | | | | | | News Article | History of Expo Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First Mercantile Trust Co | Institution | 3,600 | Added More | 510 | 16.50 % | $101,844 | $100,764 | $-1,080 | -1.06 % | $-153 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Fortaleza Asset Management Inc | Institution | 21,425 | No Change | 0 | 0 % | $606,113 | $599,686 | $-6,428 | -1.06 % | $0 | | | | | | News Article | History of Fortaleza Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 1,330 | Sold Some | -42,280 | -96.95 % | $37,626 | $37,227 | $-399 | -1.06 % | $12,684 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 136,578 | Added More | 18,323 | 15.49 % | $3,863,792 | $3,822,818 | $-40,973 | -1.06 % | $-5,497 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 384,604 | Added More | 75,477 | 24.41 % | $10,880,447 | $10,765,066 | $-115,381 | -1.06 % | $-22,643 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hambrecht And Quist Capital Management Llc | Institution | 184,402 | New Holding | 184,402 | 100 % | $5,216,733 | $5,161,412 | $-55,321 | -1.06 % | $-55,321 | | | | | | News Article | History of Hambrecht And Quist Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hbk Investments L P | Institution | 10,600 | New Holding | 10,600 | 100 % | $299,874 | $296,694 | $-3,180 | -1.06 % | $-3,180 | | | | | | News Article | History of Hbk Investments L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ironbridge Capital Management Llc | Institution | 511,212 | Added More | 90,654 | 21.55 % | $14,462,187 | $14,308,824 | $-153,364 | -1.06 % | $-27,196 | | | | | | News Article | History of Ironbridge Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jacobs Levy Equity Management Inc | Institution | | Sold All | -12,200 | -100 % | | | | -1.06 % | $3,660 | | | | | | News Article | History of Jacobs Levy Equity Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | 30,940 | Added More | 14,192 | 84.73 % | $875,293 | $866,011 | $-9,282 | -1.06 % | $-4,258 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Lord Abbett And Co Llc | Institution | 3,332,413 | Added More | 690,503 | 26.13 % | $94,273,964 | $93,274,240 | $-999,724 | -1.06 % | $-207,151 | | | | | | News Article | History of Lord Abbett And Co Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Los Angeles Capital Management And Equity Research Inc | Institution | 65,491 | New Holding | 65,491 | 100 % | $1,852,740 | $1,833,093 | $-19,647 | -1.06 % | $-19,647 | | | | | | News Article | History of Los Angeles Capital Management And Equity Research Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Managed Account Advisors Llc | Institution | 60,129 | Added More | 56,285 | 1464.22 % | $1,701,049 | $1,683,011 | $-18,039 | -1.06 % | $-16,886 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Marshall Ilsley Corp | Institution | 55,775 | Sold Some | -263 | -0.46 % | $1,577,875 | $1,561,142 | $-16,733 | -1.06 % | $79 | | | | | | News Article | History of Marshall Ilsley Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martingale Asset Management L P | Institution | 23,800 | Sold Some | -31,000 | -56.56 % | $673,302 | $666,162 | $-7,140 | -1.06 % | $9,300 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Lazard Mid Cap Portfolio | Mid-Cap Core | 104,500 | New Holding | 104,500 | 100 % | $2,956,305 | $2,924,955 | $-31,350 | -1.06 % | $-31,350 | | | | | | News Article | History of Met Investors Series Trust - Lazard Mid Cap Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Lord Abbett Mid Cap Value Portfolio | Mid-Cap Value | 48,655 | New Holding | 48,655 | 100 % | $1,376,450 | $1,361,853 | $-14,597 | -1.06 % | $-14,597 | | | | | | News Article | History of Met Investors Series Trust - Lord Abbett Mid Cap Value Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 181,770 | Added More | 164,000 | 922.90 % | $5,142,273 | $5,087,742 | $-54,531 | -1.06 % | $-49,200 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oracle Investment Management Inc | Institution | 778,000 | Added More | 228,000 | 41.45 % | $22,009,620 | $21,776,220 | $-233,400 | -1.06 % | $-68,400 | | | | | | News Article | History of Oracle Investment Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 4,552 | Added More | 3,254 | 250.69 % | $128,776 | $127,410 | $-1,366 | -1.06 % | $-976 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Paradigm Asset Management Co Llc | Institution | | Sold All | -9,500 | -100 % | | | | -1.06 % | $2,850 | | | | | | News Article | History of Paradigm Asset Management Co Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 3,356,588 | Added More | 1,170,600 | 53.55 % | $94,957,875 | $93,950,898 | $-1,006,976 | -1.06 % | $-351,180 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | 13,326 | New Holding | 13,326 | 100 % | $376,993 | $372,995 | $-3,998 | -1.06 % | $-3,998 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 10,905 | Added More | 10,255 | 1577.69 % | $308,502 | $305,231 | $-3,272 | -1.06 % | $-3,077 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 31,633 | Sold Some | -55,200 | -63.57 % | $894,898 | $885,408 | $-9,490 | -1.06 % | $16,560 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Segall Bryant And Hamill | Institution | 11,500 | No Change | 0 | 0 % | $325,335 | $321,885 | $-3,450 | -1.06 % | $0 | | | | | | News Article | History of Segall Bryant And Hamill Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sei Trust Co | Institution | 8,327 | New Holding | 8,327 | 100 % | $235,571 | $233,073 | $-2,498 | -1.06 % | $-2,498 | | | | | | News Article | History of Sei Trust Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sg Americas Securities Llc | Institution | | Sold All | -17,749 | -100 % | | | | -1.06 % | $5,325 | | | | | | News Article | History of Sg Americas Securities Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Tokum Capital Management Lp | Institution | | Sold All | -77,277 | -100 % | | | | -1.06 % | $23,183 | | | | | | News Article | History of Tokum Capital Management Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Tudor Investment Corp Et Al | Institution | 15,727 | New Holding | 15,727 | 100 % | $444,917 | $440,199 | $-4,718 | -1.06 % | $-4,718 | | | | | | News Article | History of Tudor Investment Corp Et Al Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 2,419,922 | Added More | 147,269 | 6.48 % | $68,459,593 | $67,733,617 | $-725,977 | -1.06 % | $-44,181 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Inc | Institution | 50,000 | Added More | 20,000 | 66.66 % | $1,433,000 | $1,399,500 | $-33,500 | -2.33 % | $-13,400 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | 76,300 | Sold Some | -52,287 | -40.66 % | $2,186,758 | $2,135,637 | $-51,121 | -2.33 % | $35,032 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Aronson And Johnson And Ortiz Lp | Institution | 42,600 | Added More | 8,300 | 24.19 % | $1,220,916 | $1,192,374 | $-28,542 | -2.33 % | $-5,561 | | | | | | News Article | History of Aronson And Johnson And Ortiz Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 661,784 | Added More | 267,038 | 67.64 % | $18,966,729 | $18,523,334 | $-443,395 | -2.33 % | $-178,915 | | | | | | News Article | History of Bank Of America Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 3,849,723 | Added More | 554,218 | 16.81 % | $110,333,061 | $107,753,747 | $-2,579,314 | -2.33 % | $-371,326 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Columbia Wanger Asset Management Lp | Institution | 674,900 | New Holding | 674,900 | 100 % | $19,342,634 | $18,890,451 | $-452,183 | -2.33 % | $-452,183 | | | | | | News Article | History of Columbia Wanger Asset Management Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 16,471 | New Holding | 16,471 | 100 % | $472,059 | $461,023 | $-11,036 | -2.33 % | $-11,036 | | | | | | News Article | History of Credit Suisse Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson D A And Co | Institution | 31 | New Holding | 31 | 100 % | $888 | $868 | $-21 | -2.33 % | $-21 | | | | | | News Article | History of Davidson D A And Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson Investment Advisors | Institution | 31 | New Holding | 31 | 100 % | $888 | $868 | $-21 | -2.33 % | $-21 | | | | | | News Article | History of Davidson Investment Advisors Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | 800,000 | Added More | 300,000 | 60.00 % | $22,928,000 | $22,392,000 | $-536,000 | -2.33 % | $-201,000 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Engemann Asset Management | Institution | 28,445 | New Holding | 28,445 | 100 % | $815,234 | $796,176 | $-19,058 | -2.33 % | $-19,058 | | | | | | News Article | History of Engemann Asset Management Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Franklin Resources Inc | Institution | 1,367,426 | Added More | 886,981 | 184.61 % | $39,190,429 | $38,274,254 | $-916,175 | -2.33 % | $-594,277 | | | | | | News Article | History of Franklin Resources Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 386,847 | Added More | 11,210 | 2.98 % | $11,087,035 | $10,827,848 | $-259,187 | -2.33 % | $-7,511 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Knott David M | Institution | 667,468 | Added More | 73,700 | 12.41 % | $19,129,633 | $18,682,429 | $-447,204 | -2.33 % | $-49,379 | | | | | | News Article | History of Knott David M Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 310,842 | Added More | 295,535 | 1930.71 % | $8,908,732 | $8,700,468 | $-208,264 | -2.33 % | $-198,008 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 61,020 | Added More | 9,924 | 19.42 % | $1,748,833 | $1,707,950 | $-40,883 | -2.33 % | $-6,649 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Nomura Asset Management Co Ltd | Institution | 677,683 | Added More | 113,083 | 20.02 % | $19,422,395 | $18,968,347 | $-454,048 | -2.33 % | $-75,766 | | | | | | News Article | History of Nomura Asset Management Co Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Oshaughnessy Asset Management Llc | Institution | 29,183 | Added More | 27,718 | 1892.01 % | $836,385 | $816,832 | $-19,553 | -2.33 % | $-18,571 | | | | | | News Article | History of Oshaughnessy Asset Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 23,412 | Sold Some | -2,817 | -10.74 % | $670,988 | $655,302 | $-15,686 | -2.33 % | $1,887 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 129,364 | Added More | 22,133 | 20.64 % | $3,707,572 | $3,620,898 | $-86,674 | -2.33 % | $-14,829 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Palisade Capital Management Llc | Institution | 134,400 | New Holding | 134,400 | 100 % | $3,851,904 | $3,761,856 | $-90,048 | -2.33 % | $-90,048 | | | | | | News Article | History of Palisade Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Principal Financial Group Inc | Institution | | Sold All | -191,410 | -100 % | | | | -2.33 % | $128,245 | | | | | | News Article | History of Principal Financial Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rice Hall James And Associates Llc | Institution | 15,430 | No Change | 0 | 0 % | $442,224 | $431,886 | $-10,338 | -2.33 % | $0 | | | | | | News Article | History of Rice Hall James And Associates Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 193,976 | New Holding | 193,976 | 100 % | $5,559,352 | $5,429,388 | $-129,964 | -2.33 % | $-129,964 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | 2,500 | Added More | 200 | 8.69 % | $71,650 | $69,975 | $-1,675 | -2.33 % | $-134 | | | | | | News Article | History of Russell Frank Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sector Gamma Asa | No Data | 144,800 | No Compare | | | $4,149,968 | $4,052,952 | $-97,016 | -2.33 % | | | | | | | News Article | History of Sector Gamma Asa Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sovereign Asset Management Corp | Institution | 105,932 | Added More | 10,246 | 10.70 % | $3,036,011 | $2,965,037 | $-70,974 | -2.33 % | $-6,865 | | | | | | News Article | History of Sovereign Asset Management Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Stafford Asset Management Llc | No Data | 14,260 | New Holding | 14,260 | 100 % | $408,692 | $399,137 | $-9,554 | -2.33 % | $-9,554 | | | | | | News Article | History of Stafford Asset Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suffolk Capital Management Llc | Institution | 16,000 | New Holding | 16,000 | 100 % | $458,560 | $447,840 | $-10,720 | -2.33 % | $-10,720 | | | | | | News Article | History of Suffolk Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suntrust Banks Inc | Institution | 50,473 | New Holding | 50,473 | 100 % | $1,446,556 | $1,412,739 | $-33,817 | -2.33 % | $-33,817 | | | | | | News Article | History of Suntrust Banks Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 130,494 | Added More | 57,954 | 79.89 % | $3,739,958 | $3,652,527 | $-87,431 | -2.33 % | $-38,829 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Timessquare Capital Management Llc | Institution | 617,511 | New Holding | 617,511 | 100 % | $17,697,865 | $17,284,133 | $-413,732 | -2.33 % | $-413,732 | | | | | | News Article | History of Timessquare Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | United Services Automobile Association | Institution | 21,700 | Added More | 8,700 | 66.92 % | $621,922 | $607,383 | $-14,539 | -2.33 % | $-5,829 | | | | | | News Article | History of United Services Automobile Association Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Veritable L P | Institution | | Sold All | -7,600 | -100 % | | | | -2.33 % | $5,092 | | | | | | News Article | History of Veritable L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | | Sold All | -12,600 | -100 % | | | | -2.33 % | $8,442 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | World Asset Management Inc | Institution | 7,216 | No Change | 0 | 0 % | $206,811 | $201,976 | $-4,835 | -2.33 % | $0 | | | | | | News Article | History of World Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | American Century Companies Inc | Institution | 89,275 | Added More | 4,681 | 5.53 % | $2,424,709 | $2,498,807 | $74,098 | 3.05 % | $3,885 | | | | | | News Article | History of American Century Companies Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Baker Bros Advisors Llc | Institution | 200,000 | New Holding | 200,000 | 100 % | $5,432,000 | $5,598,000 | $166,000 | 3.05 % | $166,000 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 25,269 | Sold Some | -153,586 | -85.87 % | $686,306 | $707,279 | $20,973 | 3.05 % | $-127,476 | | | | | | News Article | History of Citigroup Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 9,014 | New Holding | 9,014 | 100 % | $244,820 | $252,302 | $7,482 | 3.05 % | $7,482 | | | | | | News Article | History of Comerica Bank Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 7,303 | Added More | 45 | 0.62 % | $198,349 | $204,411 | $6,061 | 3.05 % | $37 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Highbridge Capital Management Llc | Institution | 96,224 | New Holding | 96,224 | 100 % | $2,613,444 | $2,693,310 | $79,866 | 3.05 % | $79,866 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ig Investment Management Ltd | Institution | 1,500 | Added More | 50 | 3.44 % | $40,740 | $41,985 | $1,245 | 3.05 % | $42 | | | | | | News Article | History of Ig Investment Management Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 240,335 | Added More | 63,565 | 35.95 % | $6,527,499 | $6,726,977 | $199,478 | 3.05 % | $52,759 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR/A | Md Witter Investmentsllc | No Data | 22,051 | Sold Some | -181 | -0.81 % | $598,905 | $617,207 | $18,302 | 3.05 % | $-150 | | | | | | News Article | History of Md Witter Investmentsllc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Nomura Holdings Inc | Institution | 299,133 | New Holding | 299,133 | 100 % | $8,124,452 | $8,372,733 | $248,280 | 3.05 % | $248,280 | | | | | | News Article | History of Nomura Holdings Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Sectoral Asset Management Inc | Institution | 3,040,432 | Sold Some | -1,355,914 | -30.84 % | $82,578,133 | $85,101,692 | $2,523,559 | 3.05 % | $-1,125,409 | | | | | | News Article | History of Sectoral Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 226,666 | Added More | 11,648 | 5.41 % | $6,156,249 | $6,344,381 | $188,133 | 3.05 % | $9,668 | | | | | | News Article | History of Ubs Ag Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Cadence Capital Management Llc | Institution | 160,150 | Sold Some | -327,540 | -67.16 % | $4,269,599 | $4,482,599 | $213,000 | 4.98 % | $-435,628 | | | | | | News Article | History of Cadence Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Chartwell Investment Partners | Institution | 406,730 | Added More | 167,075 | 69.71 % | $10,843,422 | $11,384,373 | $540,951 | 4.98 % | $222,210 | | | | | | News Article | History of Chartwell Investment Partners Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 21,510 | New Holding | 21,510 | 100 % | $573,457 | $602,065 | $28,608 | 4.98 % | $28,608 | | | | | | News Article | History of Federated Investors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Lee Munder Capital Group Llc | No Data | 53,523 | No Compare | | | $1,426,923 | $1,498,109 | $71,186 | 4.98 % | | | | | | | News Article | History of Lee Munder Capital Group Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | North Pointe Capital Llc | Institution | | Sold All | -172,021 | -100 % | | | | 4.98 % | $-228,788 | | | | | | News Article | History of North Pointe Capital Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 57,000 | Added More | 16,900 | 42.14 % | $1,519,620 | $1,595,430 | $75,810 | 4.98 % | $22,477 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Rima Management Llc | Institution | 275,999 | Added More | 93,500 | 51.23 % | $7,358,133 | $7,725,212 | $367,079 | 4.98 % | $124,355 | | | | | | News Article | History of Rima Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | State Of Wisconsin Investment Board | Institution | 30,000 | New Holding | 30,000 | 100 % | $799,800 | $839,700 | $39,900 | 4.98 % | $39,900 | | | | | | News Article | History of State Of Wisconsin Investment Board Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Ar Asset Managment Inc | Institution | 10,000 | No Change | 0 | 0 % | $266,000 | $279,900 | $13,900 | 5.22 % | $0 | | | | | | News Article | History of Ar Asset Managment Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Hartford Investment Management Co | Institution | 150,442 | Added More | 31,500 | 26.48 % | $4,001,757 | $4,210,872 | $209,114 | 5.22 % | $43,785 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metlife Securities Inc | Institution | 4,673 | Added More | 3,623 | 345.04 % | $124,302 | $130,797 | $6,495 | 5.22 % | $5,036 | | | | | | News Article | History of Metlife Securities Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 55,512 | Added More | 4,288 | 8.37 % | $1,476,619 | $1,553,781 | $77,162 | 5.22 % | $5,960 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pioneer Investment Management Inc | Institution | | Sold All | -50,500 | -100 % | | | | 5.22 % | $-70,195 | | | | | | News Article | History of Pioneer Investment Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 100 | Sold Some | -639 | -86.46 % | $2,660 | $2,799 | $139 | 5.22 % | $-888 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 15,500 | Sold Some | -9,000 | -36.73 % | $412,300 | $433,845 | $21,545 | 5.22 % | $-12,510 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tcw Group Inc | Institution | 37,500 | Sold Some | -5,400 | -12.58 % | $997,500 | $1,049,625 | $52,125 | 5.22 % | $-7,506 | | | | | | News Article | History of Tcw Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 131,124 | Added More | 8,798 | 7.19 % | $3,487,898 | $3,670,161 | $182,262 | 5.22 % | $12,229 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 361,610 | Added More | 28,292 | 8.48 % | $9,618,826 | $10,121,464 | $502,638 | 5.22 % | $39,326 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Trilogy Global Advisors Llc | Institution | | Sold All | -18,700 | -100 % | | | | 5.22 % | $-25,993 | | | | | | News Article | History of Trilogy Global Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Unionbancal Corp | Institution | 1,200 | No Change | 0 | 0 % | $31,920 | $33,588 | $1,668 | 5.22 % | $0 | | | | | | News Article | History of Unionbancal Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii - All Cap Growth Fund | Multi-Cap Growth | 25,330 | New Holding | 25,330 | 100 % | $673,778 | $708,987 | $35,209 | 5.22 % | $35,209 | | | | | | News Article | History of John Hancock Funds Ii - All Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii - All Cap Value Fund | Multi-Cap Core | | Sold All | -42,200 | -100 % | | | | 5.22 % | $-58,658 | | | | | | News Article | History of John Hancock Funds Ii - All Cap Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii - Value Fund | Multi-Cap Core | 30,000 | New Holding | 30,000 | 100 % | $798,000 | $839,700 | $41,700 | 5.22 % | $41,700 | | | | | | News Article | History of John Hancock Funds Ii - Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | Valic Co Ii - Small Cap Value Fund | Small-Cap Value | 10,300 | Added More | 2,500 | 32.05 % | $273,980 | $288,297 | $14,317 | 5.22 % | $3,475 | | | | | | News Article | History of Valic Co Ii - Small Cap Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Bank Of Hawaii | Institution | 9,800 | Sold Some | -5,700 | -36.77 % | $260,386 | $274,302 | $13,916 | 5.34 % | $-8,094 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Fixed Income Securities Lp | Institution | 154 | New Holding | 154 | 100 % | $4,092 | $4,310 | $219 | 5.34 % | $219 | | | | | | News Article | History of Fixed Income Securities Lp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Nisa Investment Advisors L L C | Institution | 10,000 | Sold Some | -3,200 | -24.24 % | $265,700 | $279,900 | $14,200 | 5.34 % | $-4,544 | | | | | | News Article | History of Nisa Investment Advisors L L C Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 36,038 | Added More | 1,424 | 4.11 % | $957,530 | $1,008,704 | $51,174 | 5.34 % | $2,022 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 10,476 | Added More | 978 | 10.29 % | $278,347 | $293,223 | $14,876 | 5.34 % | $1,389 | | | | | | News Article | History of Profund Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 17,584 | Sold Some | -6,634 | -27.39 % | $467,207 | $492,176 | $24,969 | 5.34 % | $-9,420 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Curian Capital Llc | Institution | 11,695 | New Holding | 11,695 | 100 % | $308,514 | $327,343 | $18,829 | 6.10 % | $18,829 | | | | | | News Article | History of Curian Capital Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Fort Washington Investment Advisors Inc | Institution | 180,135 | Added More | 14,160 | 8.53 % | $4,751,961 | $5,041,979 | $290,017 | 6.10 % | $22,798 | | | | | | News Article | History of Fort Washington Investment Advisors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 47,900 | New Holding | 47,900 | 100 % | $1,263,602 | $1,340,721 | $77,119 | 6.10 % | $77,119 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Tradeworx Inc | Institution | 21,504 | New Holding | 21,504 | 100 % | $567,276 | $601,897 | $34,621 | 6.10 % | $34,621 | | | | | | News Article | History of Tradeworx Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Alliancebernstein Portfolios - Alliancebernstein Growth Fund | Multi-Cap Growth | 180,700 | New Holding | 180,700 | 100 % | $4,766,866 | $5,057,793 | $290,927 | 6.10 % | $290,927 | | | | | | News Article | History of Alliancebernstein Portfolios - Alliancebernstein Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Ixis Asset Management Advisors L P | Institution | 12,351 | Sold Some | -701 | -5.37 % | $336,565 | $345,704 | $9,140 | 2.71 % | $-519 | | | | | | News Article | History of Ixis Asset Management Advisors L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | M And T Bank Corp | Institution | | Sold All | -20,225 | -100 % | | | | 2.71 % | $-14,967 | | | | | | News Article | History of M And T Bank Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Sparta Asset Management Llc | Institution | 93,582 | New Holding | 93,582 | 100 % | $2,550,110 | $2,619,360 | $69,251 | 2.71 % | $69,251 | | | | | | News Article | History of Sparta Asset Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 171,370 | Added More | 159,780 | 1378.60 % | $4,669,833 | $4,796,646 | $126,814 | 2.71 % | $118,237 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Emerald Advisers Inc | Institution | 84,296 | New Holding | 84,296 | 100 % | $2,229,629 | $2,359,445 | $129,816 | 5.82 % | $129,816 | | | | | | News Article | History of Emerald Advisers Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Emerald Mutual Fund Advisers Trust | Institution | 34,540 | New Holding | 34,540 | 100 % | $913,583 | $966,775 | $53,192 | 5.82 % | $53,192 | | | | | | News Article | History of Emerald Mutual Fund Advisers Trust Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | 1,500 | Sold Some | -9,000 | -85.71 % | $39,675 | $41,985 | $2,310 | 5.82 % | $-13,860 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 277,552 | Sold Some | -122,000 | -30.53 % | $7,341,250 | $7,768,680 | $427,430 | 5.82 % | $-187,880 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 64,468 | Added More | 49,962 | 344.42 % | $1,714,849 | $1,804,459 | $89,611 | 5.22 % | $69,447 | | | | | | News Article | History of Oxford Asset Management Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Stonebridge Capital Management Inc | Institution | 19,655 | Sold Some | -4,970 | -20.18 % | $522,823 | $550,143 | $27,320 | 5.22 % | $-6,908 | | | | | | News Article | History of Stonebridge Capital Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Balanced Fund | Mixed-Asset Target Allocation Moderate | 20,978 | Added More | 5,889 | 39.02 % | $558,015 | $587,174 | $29,159 | 5.22 % | $8,186 | | | | | | News Article | History of Fidelity Advisor Series I - Balanced Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Growth Opportunities Fund | Large-Cap Core | 43,700 | New Holding | 43,700 | 100 % | $1,162,420 | $1,223,163 | $60,743 | 5.22 % | $60,743 | | | | | | News Article | History of Fidelity Advisor Series I - Growth Opportunities Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 2,226 | No Compare | | | $59,212 | $62,306 | $3,094 | 5.22 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSRS | Fidelity Commonwealth Trust Ii - Fidelity Small Cap Enhanced Index Fund | Small-Cap Core | 300 | Sold Some | -780 | -72.22 % | $7,980 | $8,397 | $417 | 5.22 % | $-1,084 | | | | | | News Article | History of Fidelity Commonwealth Trust Ii - Fidelity Small Cap Enhanced Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund | Multi-Cap Growth | | Sold All | -30,000 | -100 % | | | | 5.22 % | $-41,700 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Growth Company Fund | Multi-Cap Growth | 1,000,000 | Added More | 451,988 | 82.47 % | $26,600,000 | $27,990,000 | $1,390,000 | 5.22 % | $628,263 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Growth Company Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Lord Abbett Research Fund Inc - Americas Value Fund | Multi-Cap Value | 949,118 | New Holding | 949,118 | 100 % | $25,246,539 | $26,565,813 | $1,319,274 | 5.22 % | $1,319,274 | | | | | | News Article | History of Lord Abbett Research Fund Inc - Americas Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Lord Abbett Research Fund Inc - Growth Opportunities Fund | Mid-Cap Growth | 43,857 | New Holding | 43,857 | 100 % | $1,166,596 | $1,227,557 | $60,961 | 5.22 % | $60,961 | | | | | | News Article | History of Lord Abbett Research Fund Inc - Growth Opportunities Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 27,829 | New Holding | 27,829 | 100 % | $740,251 | $778,934 | $38,682 | 5.22 % | $38,682 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 77,565 | Sold Some | -5,600 | -6.73 % | $2,008,158 | $2,171,044 | $162,887 | 8.11 % | $-11,760 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Lyz Capital Advisors Llc | Institution | 28,952 | Added More | 7,000 | 31.88 % | $749,567 | $810,366 | $60,799 | 8.11 % | $14,700 | | | | | | News Article | History of Lyz Capital Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Forum Funds - Shaker Fund | Specialty & Misc | | Sold All | -5,900 | -100 % | | | | 8.11 % | $-12,390 | | | | | | News Article | History of Forum Funds - Shaker Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Riversource Equity Series Inc - Riversource Mid Cap Growth Fund | Mid-Cap Growth | 87,675 | New Holding | 87,675 | 100 % | $2,269,906 | $2,454,023 | $184,118 | 8.11 % | $184,118 | | | | | | News Article | History of Riversource Equity Series Inc - Riversource Mid Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -3,300 | -100 % | | | | 8.11 % | $-6,930 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Health Sciences Fund | Health/Biotech | 28,800 | No Change | 0 | 0 % | $745,632 | $806,112 | $60,480 | 8.11 % | $0 | | | | | | News Article | History of Valic Co I - Health Sciences Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Fund | Small-Cap Core | 3,600 | New Holding | 3,600 | 100 % | $93,204 | $100,764 | $7,560 | 8.11 % | $7,560 | | | | | | News Article | History of Valic Co I - Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 49,970 | New Holding | 49,970 | 100 % | $1,293,723 | $1,398,660 | $104,937 | 8.11 % | $104,937 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Brazos Mutual Funds - Brazos Small Cap Portfolio | Small-Cap Growth | 5,100 | New Holding | 5,100 | 100 % | $128,163 | $142,749 | $14,586 | 11.38 % | $14,586 | | | | | | News Article | History of Brazos Mutual Funds - Brazos Small Cap Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Dupont Capital Management | Institution | 67,114 | New Holding | 67,114 | 100 % | $1,712,078 | $1,878,521 | $166,443 | 9.72 % | $166,443 | | | | | | News Article | History of Dupont Capital Management Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Forward Management Llc | Institution | 250 | No Change | 0 | 0 % | $6,378 | $6,998 | $620 | 9.72 % | $0 | | | | | | News Article | History of Forward Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Schroder Investment Management Group | Institution | 500,700 | New Holding | 500,700 | 100 % | $12,592,605 | $14,014,593 | $1,421,988 | 11.29 % | $1,421,988 | | | | | | News Article | History of Schroder Investment Management Group Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | 30 | No Change | 0 | 0 % | $755 | $840 | $85 | 11.29 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-CSR | Eaton Vance Growth Trust - Eaton Vance Worldwide Health Sciences Fund | Health/Biotech | | Sold All | -1,351,200 | -100 % | | | | 11.29 % | $-3,837,408 | | | | | | News Article | History of Eaton Vance Growth Trust - Eaton Vance Worldwide Health Sciences Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Legg Mason Partners Equity Trust - Legg Mason Partners Mid Cap Core Fund | Mid-Cap Core | | Sold All | -440,000 | -100 % | | | | 11.29 % | $-1,249,600 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners Mid Cap Core Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2010 Exchange-Traded Fund | Mixed-Asset Target 2010 Funds | | Sold All | -85 | -100 % | | | | 11.29 % | $-241 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2010 Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2020 Exchange-Traded Fund | Mixed-Asset Target 2020 Funds | | Sold All | -553 | -100 % | | | | 11.29 % | $-1,571 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2020 Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2030 Exchange-Traded Fund | Mixed-Asset Target 2030 Funds | | Sold All | -648 | -100 % | | | | 11.29 % | $-1,840 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2030 Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2040 Exchange-Traded Fund | Mixed-Asset Target 2030+ Funds | | Sold All | -768 | -100 % | | | | 11.29 % | $-2,181 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2040 Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence In-Target Exchange-Traded Fund | Specialty & Misc | | Sold All | -75 | -100 % | | | | 11.29 % | $-213 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence In-Target Exchange-Traded Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-CSR | Worldwide Health Sciences Portfolio - Worldwide Health Sciences | Health/Biotech | | Sold All | -1,351,200 | -100 % | | | | 11.29 % | $-3,837,408 | | | | | | News Article | History of Worldwide Health Sciences Portfolio - Worldwide Health Sciences Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 130,536 | Sold Some | -34,836 | -21.06 % | $3,282,980 | $3,653,703 | $370,722 | 11.29 % | $-98,934 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Pinnacle Associates Ltd | Institution | 504,190 | Added More | 5,330 | 1.06 % | $12,811,468 | $14,112,278 | $1,300,810 | 10.15 % | $13,751 | | | | | | News Article | History of Pinnacle Associates Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Apex Capital Management | Institution | 68,177 | Added More | 64,111 | 1576.75 % | $1,751,467 | $1,908,274 | $156,807 | 8.95 % | $147,455 | | | | | | News Article | History of Apex Capital Management Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Advisors Llc | Institution | 517,300 | Added More | 407,300 | 370.27 % | $13,289,437 | $14,479,227 | $1,189,790 | 8.95 % | $936,790 | | | | | | News Article | History of Blackrock Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 174,622 | Added More | 79,000 | 82.61 % | $4,486,039 | $4,887,670 | $401,631 | 8.95 % | $181,700 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 42,800 | Added More | 24,326 | 131.67 % | $1,099,532 | $1,197,972 | $98,440 | 8.95 % | $55,950 | | | | | | News Article | History of Blackrock Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 189,450 | Added More | 59,344 | 45.61 % | $4,866,971 | $5,302,706 | $435,735 | 8.95 % | $136,491 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Eagle Asset Management Inc | Institution | 597,208 | Added More | 72,180 | 13.74 % | $15,342,274 | $16,715,852 | $1,373,578 | 8.95 % | $166,014 | | | | | | News Article | History of Eagle Asset Management Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Merrill Lynch Mercury Asset Management Japan Ltd | Institution | 2,800 | New Holding | 2,800 | 100 % | $71,932 | $78,372 | $6,440 | 8.95 % | $6,440 | | | | | | News Article | History of Merrill Lynch Mercury Asset Management Japan Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 282,178 | Sold Some | -305,529 | -51.98 % | $7,102,420 | $7,898,162 | $795,742 | 11.20 % | $-861,592 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Credo Capital Management Llc | Institution | 19,780 | No Change | 0 | 0 % | $497,863 | $553,642 | $55,780 | 11.20 % | $0 | | | | | | News Article | History of Credo Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 87,877 | Added More | 24,004 | 37.58 % | $2,211,864 | $2,459,677 | $247,813 | 11.20 % | $67,691 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 58,300 | No Change | 0 | 0 % | $1,466,245 | $1,631,817 | $165,572 | 11.29 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Teachers Retirement System Of The State Of Kentucky | Institution | 15,900 | No Change | 0 | 0 % | $399,885 | $445,041 | $45,156 | 11.29 % | $0 | | | | | | News Article | History of Teachers Retirement System Of The State Of Kentucky Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 159,782 | Added More | 11,782 | 7.96 % | $4,154,332 | $4,472,298 | $317,966 | 7.65 % | $23,446 | | | | | | News Article | History of Strs Ohio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Pillar Point Equity Management Llc | Institution | 5,200 | No Change | 0 | 0 % | $140,868 | $145,548 | $4,680 | 3.32 % | $0 | | | | | | News Article | History of Pillar Point Equity Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 76,996 | Added More | 7,596 | 10.94 % | $2,085,822 | $2,155,118 | $69,296 | 3.32 % | $6,836 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-15 | 2007-03-31 | 13F-HR/A | Northwestern Mutual Life Insurance Co | Institution | | Sold All | -310 | -100 % | | | | 3.32 % | $-279 | | | | | | News Article | History of Northwestern Mutual Life Insurance Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | Lord Abbett Developing Growth Fund Inc New - Lord Abbett Developing Growth Fund Inc New | Small-Cap Growth | 168,800 | Sold Some | -370 | -0.21 % | $4,540,720 | $4,724,712 | $183,992 | 4.05 % | $-403 | | | | | | News Article | History of Lord Abbett Developing Growth Fund Inc New - Lord Abbett Developing Growth Fund Inc New Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | World Funds Trust - Commonwealth Small Cap Fund | No Data | 250 | New Holding | 250 | 100 % | $6,725 | $6,998 | $273 | 4.05 % | $273 | | | | | | News Article | History of World Funds Trust - Commonwealth Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 86,069 | Added More | 5,516 | 6.84 % | $2,370,340 | $2,409,071 | $38,731 | 1.63 % | $2,482 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-09-30 | 13F-HR | Boston Private Bank And Trust Co | Institution | | Sold All | -13,300 | -100 % | | | | 0.14 % | $-532 | | | | | | News Article | History of Boston Private Bank And Trust Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 29,896 | Added More | 11,448 | 62.05 % | $835,593 | $836,789 | $1,196 | 0.14 % | $458 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund | Health/Biotech | | Sold All | -22,103 | -100 % | | | | 0.14 % | $-884 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSRS | Fidelity Devonshire Trust - Fidelity Series All-Sector Equity Fund | No Data | 225,635 | Added More | 125,565 | 125.47 % | $6,306,498 | $6,315,524 | $9,025 | 0.14 % | $5,023 | | | | | | News Article | History of Fidelity Devonshire Trust - Fidelity Series All-Sector Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Bull Profund | Large-Cap Core | 2,120 | Added More | 1,050 | 98.13 % | $59,254 | $59,339 | $85 | 0.14 % | $42 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Health Care Ultrasector Profund | Health/Biotech | 219 | Added More | 117 | 114.70 % | $6,121 | $6,130 | $9 | 0.14 % | $5 | | | | | | News Article | History of Profunds - Health Care Ultrasector Profund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Technology Ultrasector Profund | Science & Tech | 2,856 | New Holding | 2,856 | 100 % | $79,825 | $79,939 | $114 | 0.14 % | $114 | | | | | | News Article | History of Profunds - Technology Ultrasector Profund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Franklin Street Advisors Inc | Institution | 37,050 | Added More | 1,100 | 3.05 % | $1,051,850 | $1,037,030 | $-14,820 | -1.40 % | $-440 | | | | | | News Article | History of Franklin Street Advisors Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Cap Fund Inc - Alliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 85,000 | Added More | 14,700 | 20.91 % | $2,455,650 | $2,379,150 | $-76,500 | -3.11 % | $-13,230 | | | | | | News Article | History of Alliancebernstein Cap Fund Inc - Alliancebernstein Small Cap Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Mid Cap Growth Fund Inc - Alliancebernstein Mid Cap Growth Fund Inc | Mid-Cap Growth | 118,900 | Added More | 20,000 | 20.22 % | $3,435,021 | $3,328,011 | $-107,010 | -3.11 % | $-18,000 | | | | | | News Article | History of Alliancebernstein Mid Cap Growth Fund Inc - Alliancebernstein Mid Cap Growth Fund Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Pacific Capital Funds - Small Cap Fund | Small-Cap Value | 13,600 | Sold Some | -3,600 | -20.93 % | $392,904 | $380,664 | $-12,240 | -3.11 % | $3,240 | | | | | | News Article | History of Pacific Capital Funds - Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | | Sold All | -13,000 | -100 % | | | | -3.11 % | $11,700 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - New Opportunities Fund | Small-Cap Growth | 18,047 | Sold Some | -1,838 | -9.24 % | $578,587 | $505,136 | $-73,451 | -12.69 % | $7,481 | | | | | | News Article | History of American Century Mutual Funds Inc - New Opportunities Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - New Opportunities Ii | Small-Cap Growth | 61,447 | Sold Some | -12,321 | -16.70 % | $1,969,991 | $1,719,902 | $-250,089 | -12.69 % | $50,146 | | | | | | News Article | History of American Century Mutual Funds Inc - New Opportunities Ii Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 45,700 | New Holding | 45,700 | 100 % | $1,465,142 | $1,279,143 | $-185,999 | -12.69 % | $-185,999 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 4,600 | New Holding | 4,600 | 100 % | $147,476 | $128,754 | $-18,722 | -12.69 % | $-18,722 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 900 | New Holding | 900 | 100 % | $28,854 | $25,191 | $-3,663 | -12.69 % | $-3,663 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Evergreen Equity Trust De - Evergreen Health Care Fund | Health/Biotech | 79,557 | Sold Some | -10,475 | -11.63 % | $2,550,597 | $2,226,800 | $-323,797 | -12.69 % | $42,633 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Health Care Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc - Small Cap Growth Opportunities Fund | Small-Cap Growth | 32,233 | New Holding | 32,233 | 100 % | $1,033,390 | $902,202 | $-131,188 | -12.69 % | $-131,188 | | | | | | News Article | History of First American Investment Funds Inc - Small Cap Growth Opportunities Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc - Small Cap Select Fund | Small-Cap Core | 94,367 | New Holding | 94,367 | 100 % | $3,025,406 | $2,641,332 | $-384,074 | -12.69 % | $-384,074 | | | | | | News Article | History of First American Investment Funds Inc - Small Cap Select Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Heritage Series Trust - Diversified Growth Fund | Multi-Cap Growth | 87,265 | No Change | 0 | 0 % | $2,797,716 | $2,442,547 | $-355,169 | -12.69 % | $0 | | | | | | News Article | History of Heritage Series Trust - Diversified Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Small Growth Index Fund | Small-Cap Growth | 18,824 | Added More | 3,597 | 23.62 % | $603,497 | $526,884 | $-76,614 | -12.69 % | $-14,640 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Small Growth Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Fund | Large-Cap Growth | 271,613 | New Holding | 271,613 | 100 % | $8,707,913 | $7,602,448 | $-1,105,465 | -12.69 % | $-1,105,465 | | | | | | News Article | History of Janus Investment Fund - Janus Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 587 | No Change | 0 | 0 % | $18,819 | $16,430 | $-2,389 | -12.69 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Mainstay Funds - Mainstay Small Cap Growth Fund | Small-Cap Growth | 20,700 | Added More | 800 | 4.02 % | $663,642 | $579,393 | $-84,249 | -12.69 % | $-3,256 | | | | | | News Article | History of Mainstay Funds - Mainstay Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund - Vanguard Explorer Fund | Small-Cap Growth | 204,493 | Added More | 4,843 | 2.42 % | $6,556,046 | $5,723,759 | $-832,287 | -12.69 % | $-19,711 | | | | | | News Article | History of Vanguard Explorer Fund - Vanguard Explorer Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-CSRS | Vanguard Specialized Funds - Vanguard Health Care Fund | Health/Biotech | 807,200 | New Holding | 807,200 | 100 % | $25,878,832 | $22,593,528 | $-3,285,304 | -12.69 % | $-3,285,304 | | | | | | News Article | History of Vanguard Specialized Funds - Vanguard Health Care Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Harbor Funds - Harbor Mid Cap Growth Fund | Mid-Cap Growth | | Sold All | -44,274 | -100 % | | | | -13.87 % | $199,676 | | | | | | News Article | History of Harbor Funds - Harbor Mid Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Harbor Funds - Harbor Small Company Growth Fund | Small-Cap Growth | 13,458 | New Holding | 13,458 | 100 % | $437,385 | $376,689 | $-60,696 | -13.87 % | $-60,696 | | | | | | News Article | History of Harbor Funds - Harbor Small Company Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Mid Cap Core Portfolio | Mid-Cap Core | 35,000 | Added More | 13,000 | 59.09 % | $1,137,500 | $979,650 | $-157,850 | -13.87 % | $-58,630 | | | | | | News Article | History of Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Mid Cap Core Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Lord Abbett Securities Trust - Lord Abbett All Value Fund | Multi-Cap Value | | Sold All | -1,042,900 | -100 % | | | | -13.87 % | $4,703,479 | | | | | | News Article | History of Lord Abbett Securities Trust - Lord Abbett All Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -900 | -100 % | | | | -13.87 % | $4,059 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -1,700 | -100 % | | | | -13.87 % | $7,667 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Market Portfolio | Specialty & Misc | | Sold All | -116,911 | -100 % | | | | -13.87 % | $527,269 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Market Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio | No Data | 1,285 | Added More | 88 | 7.35 % | $41,763 | $35,967 | $-5,795 | -13.87 % | $-397 | | | | | | News Article | History of Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Small Cap Bull 3x Shares | No Data | | Sold All | -17,271 | -100 % | | | | -12.22 % | $67,357 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Small Cap Bull 3x Shares Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Multi Cap Growth Fund | Multi-Cap Core | 350 | Sold Some | -75 | -17.64 % | $11,162 | $9,797 | $-1,365 | -12.22 % | $293 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Multi Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Small Cap Growth Fund | Small-Cap Growth | 19,000 | Added More | 7,500 | 65.21 % | $605,910 | $531,810 | $-74,100 | -12.22 % | $-29,250 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Stonebridge Funds Trust - Stonebridge Growth Fund | Multi-Cap Growth | 10,750 | New Holding | 10,750 | 100 % | $342,818 | $300,893 | $-41,925 | -12.22 % | $-41,925 | | | | | | News Article | History of Stonebridge Funds Trust - Stonebridge Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | | Sold All | -161 | -100 % | | | | -12.22 % | $628 | | | | | | News Article | History of Kbc Group Nv Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Forum Funds - Shaker Fund | Specialty & Misc | 5,900 | New Holding | 5,900 | 100 % | $186,145 | $165,141 | $-21,004 | -11.28 % | $-21,004 | | | | | | News Article | History of Forum Funds - Shaker Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 8,627 | Added More | 4,667 | 117.85 % | $272,182 | $241,470 | $-30,712 | -11.28 % | $-16,615 | | | | | | News Article | History of Credit Agricole S A Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfus Premier Opportunity Funds - Health Care Fund | Health/Biotech | 4,850 | Sold Some | -1,950 | -28.67 % | $164,706 | $135,752 | $-28,955 | -17.57 % | $11,642 | | | | | | News Article | History of Dreyfus Premier Opportunity Funds - Health Care Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 13,400 | New Holding | 13,400 | 100 % | $471,144 | $375,066 | $-96,078 | -20.39 % | $-96,078 | | | | | | News Article | History of Eaton Vance Management Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 1,220 | New Holding | 1,220 | 100 % | $42,139 | $34,148 | $-7,991 | -18.96 % | $-7,991 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-17 | 2009-06-30 | 13F-HR/A | Delaware Management Business Trust | Institution | 124,465 | Added More | 20,205 | 19.37 % | $4,299,021 | $3,483,775 | $-815,246 | -18.96 % | $-132,343 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-15 | 2009-06-30 | N-CSRS/A | Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio | Small-Cap Growth | | Sold All | -550 | -100 % | | | | -20.59 % | $3,993 | | | | | | News Article | History of Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-15 | 2009-03-31 | 13F-HR/A | Highbridge Capital Management Llc | Institution | 153,598 | New Holding | 153,598 | 100 % | $5,414,330 | $4,299,208 | $-1,115,121 | -20.59 % | $-1,115,121 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-15 | 2008-03-31 | 13F-HR/A | Segall Bryant And Hamill | Institution | 11,500 | No Change | 0 | 0 % | $405,375 | $321,885 | $-83,490 | -20.59 % | $0 | | | | | | News Article | History of Segall Bryant And Hamill Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 3,295,505 | Added More | 72,552 | 2.25 % | $115,210,855 | $92,241,185 | $-22,969,670 | -19.93 % | $-505,687 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-10 | 2009-06-30 | 13F-HR/A | Veritable L P | Institution | 7,600 | New Holding | 7,600 | 100 % | $264,100 | $212,724 | $-51,376 | -19.45 % | $-51,376 | | | | | | News Article | History of Veritable L P Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-09 | 2009-06-30 | N-CSRS | Value Line Centurion Fund Inc - Value Line Centurion Fund Inc | Multi-Cap Value | | Sold All | -35,000 | -100 % | | | | -17.16 % | $203,000 | | | | | | News Article | History of Value Line Centurion Fund Inc - Value Line Centurion Fund Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-09 | 2009-06-30 | N-CSRS | Value Line Fund Inc - Value Line Fund Inc | Multi-Cap Growth | | Sold All | -26,000 | -100 % | | | | -17.16 % | $150,800 | | | | | | News Article | History of Value Line Fund Inc - Value Line Fund Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Jpmorgan Trust Ii - Jpmorgan Technology Fund | Science & Tech | 5 | New Holding | 5 | 100 % | $162 | $140 | $-22 | -13.69 % | $-22 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Technology Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 38,716 | Added More | 36,920 | 2055.67 % | $1,255,560 | $1,083,661 | $-171,899 | -13.69 % | $-163,925 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 24,489 | Added More | 6,966 | 39.75 % | $794,178 | $685,447 | $-108,731 | -13.69 % | $-30,929 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Timothy Plan - Timothy Aggressive Growth Fund | Multi-Cap Growth | | Sold All | -2,125 | -100 % | | | | -13.69 % | $9,435 | | | | | | News Article | History of Timothy Plan - Timothy Aggressive Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-08-17 | N-CSR | John Hancock Trust - Growth Trust | Multi-Cap Growth | 57,900 | New Holding | 57,900 | 100 % | $1,829,061 | $1,620,621 | $-208,440 | -11.39 % | $-208,440 | | | | | | News Article | History of John Hancock Trust - Growth Trust Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | American Funds Insurance Series - Growth Fund | Multi-Cap Growth | 1,000,000 | No Change | 0 | 0 % | $31,590,000 | $27,990,000 | $-3,600,000 | -11.39 % | $0 | | | | | | News Article | History of American Funds Insurance Series - Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 168,460 | Added More | 82,175 | 95.23 % | $5,321,651 | $4,715,195 | $-606,456 | -11.39 % | $-295,830 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 398,200 | Added More | 241,700 | 154.44 % | $12,579,138 | $11,145,618 | $-1,433,520 | -11.39 % | $-870,120 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 10,100 | New Holding | 10,100 | 100 % | $319,059 | $282,699 | $-36,360 | -11.39 % | $-36,360 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 185,300 | Added More | 109,800 | 145.43 % | $5,853,627 | $5,186,547 | $-667,080 | -11.39 % | $-395,280 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Forward Funds - Forward Legato Fund | Small-Cap Core | | Sold All | -7,009 | -100 % | | | | -11.39 % | $25,232 | | | | | | News Article | History of Forward Funds - Forward Legato Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Frontegra Funds Inc - Frontegra Ironbridge Smid Fund | Mid-Cap Core | | Sold All | -56,051 | -100 % | | | | -11.39 % | $201,784 | | | | | | News Article | History of Frontegra Funds Inc - Frontegra Ironbridge Smid Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Japan Fund | Japanese | | Sold All | -5 | -100 % | | | | -11.39 % | $18 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Japan Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Prime Money Market Fund | Specialty & Misc | 15 | New Holding | 15 | 100 % | $474 | $420 | $-54 | -11.39 % | $-54 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Prime Money Market Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Small Cap Core Fund | Small-Cap Core | 19 | No Change | 0 | 0 % | $600 | $532 | $-68 | -11.39 % | $0 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Small Cap Core Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Core Bond Fund | Multi-Cap Core | 19 | New Holding | 19 | 100 % | $600 | $532 | $-68 | -11.39 % | $-68 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Core Bond Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Small Cap Value Fund | Small-Cap Value | 10 | Sold Some | -1 | -9.09 % | $316 | $280 | $-36 | -11.39 % | $4 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Small Cap Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Mid Cap Growth Equity Fund | Mid-Cap Growth | | Sold All | -3,400 | -100 % | | | | -11.39 % | $12,240 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Mid Cap Growth Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Small Cap Growth Equity Fund | Small-Cap Growth | 20,150 | No Change | 0 | 0 % | $636,539 | $563,999 | $-72,540 | -11.39 % | $0 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Small Cap Growth Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Small Company Growth Fund | Small-Cap Growth | 15,095 | Added More | 4,870 | 47.62 % | $476,851 | $422,509 | $-54,342 | -11.39 % | $-17,532 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Small Company Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Bull Profund | Large-Cap Core | 1,070 | Sold Some | -1,750 | -62.05 % | $33,801 | $29,949 | $-3,852 | -11.39 % | $6,300 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Biotechnology | Health/Biotech | 3,402 | New Holding | 3,402 | 100 % | $107,469 | $95,222 | $-12,247 | -11.39 % | $-12,247 | | | | | | News Article | History of Profunds - Profund Vp Biotechnology Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Health Care | Health/Biotech | 1,512 | New Holding | 1,512 | 100 % | $47,764 | $42,321 | $-5,443 | -11.39 % | $-5,443 | | | | | | News Article | History of Profunds - Profund Vp Health Care Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 1,600 | New Holding | 1,600 | 100 % | $50,544 | $44,784 | $-5,760 | -11.39 % | $-5,760 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 51,205 | New Holding | 51,205 | 100 % | $1,617,566 | $1,433,228 | $-184,338 | -11.39 % | $-184,338 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Small Company Growth Portfolio | Small-Cap Growth | 10,700 | New Holding | 10,700 | 100 % | $338,013 | $299,493 | $-38,520 | -11.39 % | $-38,520 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Small Company Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Advisors Series Trust - Capital Advisors Growth Fund | Multi-Cap Growth | | Sold All | -1,700 | -100 % | | | | -9.24 % | $4,845 | | | | | | News Article | History of Advisors Series Trust - Capital Advisors Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund | Health/Biotech | 6 | No Change | 0 | 0 % | $185 | $168 | $-17 | -9.24 % | $0 | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc - Vp Developing Growth Portfolio | Multi-Cap Growth | | Sold All | -12,500 | -100 % | | | | -9.24 % | $35,625 | | | | | | News Article | History of Mainstay Vp Series Fund Inc - Vp Developing Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc - Vp Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -21,600 | -100 % | | | | -9.24 % | $61,560 | | | | | | News Article | History of Mainstay Vp Series Fund Inc - Vp Small Cap Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund - Mml Small Cap Growth Equity Fund | Small-Cap Growth | 7,080 | Sold Some | -300 | -4.06 % | $218,347 | $198,169 | $-20,178 | -9.24 % | $855 | | | | | | News Article | History of Mml Series Investment Fund - Mml Small Cap Growth Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 1,200 | New Holding | 1,200 | 100 % | $37,008 | $33,588 | $-3,420 | -9.24 % | $-3,420 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | New Covenant Funds - New Covenant Growth Fund | No Data | | Sold All | -1,750 | -100 % | | | | -9.24 % | $4,988 | | | | | | News Article | History of New Covenant Funds - New Covenant Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ohio National Fund Inc - Bryton Growth Portfolio | Multi-Cap Growth | | Sold All | -10,000 | -100 % | | | | -9.24 % | $28,500 | | | | | | News Article | History of Ohio National Fund Inc - Bryton Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ohio National Fund Inc - Capital Growth Portfolio | Multi-Cap Growth | | Sold All | -6,610 | -100 % | | | | -9.24 % | $18,839 | | | | | | News Article | History of Ohio National Fund Inc - Capital Growth Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 1,966 | No Compare | | | $60,631 | $55,028 | $-5,603 | -9.24 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Small-Cap Index Portfolio | No Data | 60,324 | Added More | 30,162 | 100.00 % | $1,860,392 | $1,688,469 | $-171,923 | -9.24 % | $-85,962 | | | | | | News Article | History of Pacific Select Fund - Small-Cap Index Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -679,104 | -100 % | | | | -9.24 % | $1,935,446 | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 3,385 | Sold Some | -242,463 | -98.62 % | $106,729 | $94,746 | $-11,983 | -11.22 % | $858,319 | | | | | | News Article | History of Amvescap Plc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 1,512,900 | Added More | 99,602 | 7.04 % | $47,701,737 | $42,346,071 | $-5,355,666 | -11.22 % | $-352,591 | | | | | | News Article | History of Fmr Corp Ownership Of Onyx Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds - Biotechnology Fund | Health/Biotech | 68,515 | Added More | 13,500 | 24.53 % | $2,160,278 | $1,917,735 | $-242,543 | -11.22 % | $-47,790 | | | | | | News Article | History of Rydex Series Funds - Biotechnology Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Central Investment Portfolios Llc - Fidelity Health Care | Health/Biotech | | Sold All | -35,852 | -100 % | | | | -12.72 % | $146,276 | | | | | | News Article | History of Fidelity Central Investment Portfolios Llc - Fidelity Health Care Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Mutual Of America Investment Corp - Bond Fund | Specialty & Misc | 32,519 | Added More | 279 | 0.86 % | $1,042,884 | $910,207 | $-132,678 | -12.72 % | $-1,138 | | | | | | News Article | History of Mutual Of America Investment Corp - Bond Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 687 | Added More | 87 | 14.50 % | $22,032 | $19,229 | $-2,803 | -12.72 % | $-355 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | 13,000 | New Holding | 13,000 | 100 % | $416,910 | $363,870 | $-53,040 | -12.72 % | $-53,040 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Midcap Earnings Fund | Mid-Cap Core | 127 | No Change | 0 | 0 % | $4,073 | $3,555 | $-518 | -12.72 % | $0 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Midcap Earnings Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds - Occ Value | Large-Cap Value | 54,910 | Added More | 3,155 | 6.09 % | $1,732,960 | $1,536,931 | $-196,029 | -11.31 % | $-11,263 | | | | | | News Article | History of Allianz Funds - Occ Value Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Calvert Fund - Calvert New Vision Small Cap Fund | Small-Cap Core | 24,400 | New Holding | 24,400 | 100 % | $770,064 | $682,956 | $-87,108 | -11.31 % | $-87,108 | | | | | | News Article | History of Calvert Fund - Calvert New Vision Small Cap Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Calvert Social Index Series Inc - Calvert Social Index Fund | Multi-Cap Core | 899 | No Change | 0 | 0 % | $28,372 | $25,163 | $-3,209 | -11.31 % | $0 | | | | | | News Article | History of Calvert Social Index Series Inc - Calvert Social Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust - Columbia Asset Allocation Fund Variable Series | Specialty & Misc | 863 | Sold Some | -40 | -4.42 % | $27,236 | $24,155 | $-3,081 | -11.31 % | $143 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust - Columbia Asset Allocation Fund Variable Series Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust - Columbia Small Company Growth Fund Variable Series | Small-Cap Growth | 14,859 | Sold Some | -1,880 | -11.23 % | $468,950 | $415,903 | $-53,047 | -11.31 % | $6,712 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust - Columbia Small Company Growth Fund Variable Series Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 679,976 | Sold Some | -41,334 | -5.73 % | $21,460,043 | $19,032,528 | $-2,427,514 | -11.31 % | $147,562 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 402,949 | Added More | 24,804 | 6.55 % | $12,717,070 | $11,278,543 | $-1,438,528 | -11.31 % | $-88,550 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 686,255 | Sold Some | -1,732 | -0.25 % | $21,658,208 | $19,208,277 | $-2,449,930 | -11.31 % | $6,183 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 3,566 | Sold Some | -107 | -2.91 % | $112,543 | $99,812 | $-12,731 | -11.31 % | $382 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 15,629 | Added More | 900 | 6.11 % | $493,251 | $437,456 | $-55,796 | -11.31 % | $-3,213 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds I - Loomis Sayles Bond Fund | Specialty & Misc | | Sold All | -21,222 | -100 % | | | | -11.31 % | $75,763 | | | | | | News Article | History of Loomis Sayles Funds I - Loomis Sayles Bond Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds Ii - Loomis Sayles Aggressive Growth Fund | Mid-Cap Growth | | Sold All | -33,592 | -100 % | | | | -11.31 % | $119,923 | | | | | | News Article | History of Loomis Sayles Funds Ii - Loomis Sayles Aggressive Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds Ii - Loomis Sayles Small Cap Growth Fund | Small-Cap Growth | 26,946 | Added More | 5,724 | 26.97 % | $850,416 | $754,219 | $-96,197 | -11.31 % | $-20,435 | | | | | | News Article | History of Loomis Sayles Funds Ii - Loomis Sayles Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Stock Portfolio | Multi-Cap Core | 764 | New Holding | 764 | 100 % | $24,112 | $21,384 | $-2,727 | -11.31 % | $-2,727 | | | | | | News Article | History of Seasons Series Trust - Stock Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 227,264 | Sold Some | -21,371 | -8.59 % | $7,172,452 | $6,361,119 | $-811,332 | -11.31 % | $76,294 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Equity Fund | Specialty & Misc | 38,116 | Sold Some | -214,384 | -84.90 % | $1,202,941 | $1,066,867 | $-136,074 | -11.31 % | $765,351 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Small-Cap Equity Fund | Small-Cap Core | | Sold All | -18,300 | -100 % | | | | -11.31 % | $65,331 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Small-Cap Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Global Life Sciences Portfolio | Science & Tech | 7,641 | Added More | 464 | 6.46 % | $241,226 | $213,872 | $-27,355 | -11.33 % | $-1,661 | | | | | | News Article | History of Janus Aspen Series - Global Life Sciences Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Old Mutual Advisor Funds Ii - Old Mutual Strategic Small Company Fund | Small-Cap Core | | Sold All | -3,478 | -100 % | | | | -11.33 % | $12,451 | | | | | | News Article | History of Old Mutual Advisor Funds Ii - Old Mutual Strategic Small Company Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 38,442 | Added More | 24,632 | 178.36 % | $1,213,614 | $1,075,992 | $-137,622 | -11.33 % | $-88,183 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -19,871 | -100 % | | | | -11.33 % | $71,138 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 346,089 | New Holding | 346,089 | 100 % | $10,926,030 | $9,687,031 | $-1,238,999 | -11.33 % | $-1,238,999 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 437,761 | New Holding | 437,761 | 100 % | $13,820,115 | $12,252,930 | $-1,567,184 | -11.33 % | $-1,567,184 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 527,061 | New Holding | 527,061 | 100 % | $16,639,316 | $14,752,437 | $-1,886,878 | -11.33 % | $-1,886,878 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 21,398 | Sold Some | -350 | -1.60 % | $675,535 | $598,930 | $-76,605 | -11.33 % | $1,253 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 27,198 | Added More | 5,450 | 25.05 % | $858,641 | $761,272 | $-97,369 | -11.33 % | $-19,511 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | 500,000 | Added More | 275,000 | 122.22 % | $15,600,000 | $13,995,000 | $-1,605,000 | -10.28 % | $-882,750 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Touchstone Funds Group Trust - Touchstone Healthcare And Biotechnology Fund | Health/Biotech | | Sold All | -19,540 | -100 % | | | | -10.28 % | $62,723 | | | | | | News Article | History of Touchstone Funds Group Trust - Touchstone Healthcare And Biotechnology Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Turner Funds - Turner Small Cap Growth Fund | Small-Cap Growth | | Sold All | -42,230 | -100 % | | | | -10.28 % | $135,558 | | | | | | News Article | History of Turner Funds - Turner Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR/A | Jefferies Group Inc | Institution | | Sold All | -7,500 | -100 % | | | | -10.63 % | $24,975 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Nicholas Applegate Institutional Funds - International Growth Fund | Multi-Cap Growth | 2,300 | Sold Some | -1,400 | -37.83 % | $72,036 | $64,377 | $-7,659 | -10.63 % | $4,662 | | | | | | News Article | History of Nicholas Applegate Institutional Funds - International Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-Q | Mellon Institutional Funds Investment Trust - The Boston Company Small Cap Growth Fund | Small-Cap Growth | 44,480 | New Holding | 44,480 | 100 % | $1,376,656 | $1,244,995 | $-131,661 | -9.56 % | $-131,661 | | | | | | News Article | History of Mellon Institutional Funds Investment Trust - The Boston Company Small Cap Growth Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 7,900 | New Holding | 7,900 | 100 % | $244,505 | $221,121 | $-23,384 | -9.56 % | $-23,384 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Onyx Pharmaceuticals Inc |
RSS feed for ONXX